CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39,797 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02150980
NCT02150980N/ACompleted

INORMUS 40,000: Large Observational Cohort Study of Orthopedic Trauma Patients

McMaster University·observational·Posted May 30, 2014·Updated Jun 6, 2024

In Brief

An observational study for Fractures or Dislocations. Completed, enrolled 39,797 participants across 69 sites in 26 countries.

Detailed Summary

Background: Worldwide, injuries from trauma represent a major public health problem. The World Health Organization (WHO) has deemed this problem as one of the most important global priorities, calling 2011-2020 the 'Decade of Action for Road Safety'. Despite this, there is little empirical data in low and middle-income countries quantifying the burden of musculoskeletal injuries. Methods: INORMUS is a global, prospective, multi-center, observational cohort study. The primary objective of the study is to determine the mortality, re-operation and infection rates of musculoskeletal trauma patients within 30 days post-hospital admission. The INORMUS study seeks to enroll 40,000 patients from low-middle income countries in Africa, Asia, and Latin America.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Botswana, Brazil, Cameroon, China, Colombia, Ethiopia, Ghana, India, Iran, Kenya, Malawi, Mexico, Nepal, Nigeria, Pakistan, Panama, Paraguay, Philippines, Rwanda, South Africa, Tanzania, Thailand, Uganda, Venezuela, Vietnam

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 30, 2014
Enrollment StartApr 1, 2014
Primary CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 9.6 yearsPosted 12.1 years ago